Shreya Shukla
Site : CDL-Paris
Stream: BioTech
Shreya Shukla, PhD, is the Program Director at Novo Nordisk Foundation Cellerator in Copenhagen, where she oversees the cell therapy development program portfolio. In this role, she drives program portfolio strategy, CMC program design, and operational program governance from late discovery through Phase I/II clinical manufacturing. She enables cross-functional collaboration with teams across Business Development, Process & Analytical Development, and GMP Operations, while closely partnering with clients to translate breakthrough science into clinical reality.
Shreya brings over 20 years of experience in stem cell bioengineering, allogeneic and autologous cell therapies, CMC drug product development, and company creation. Most recently, she headed Analytical Development at Thermo Fisher Scientific’s cell therapy manufacturing CDMO facility in San Francisco. Previously, she co-founded Notch Therapeutics—Canada’s first biotech developing renewable, stem cell-derived CAR-T cell therapies—where she served as Director of Research in Vancouver. Prior to that, she was a Scientist-Entrepreneur at CCRM in Toronto, driving the creation and launch of Notch Therapeutics from CCRM’s company incubation program. Shreya holds a PhD in Biomedical Engineering from the University of Toronto and a BS in Biomedical Engineering from Georgia Institute of Technology.